All Type of News
Dong-A’s Leucostim goes to Turkey
“Leucostim”, a treatment for neutropenia, is to be export to Turkey, Dong-A Pharmaceutical has announced on October 28.
It is going to export $20 million's worth of Leucostim to DEM ilac in Turkey for the next five...
Pharmacists staging signature campaign against doctor’s drug dispensing
The Seoul Pharmaceutical Association expressed its fir determination to oppose doctor’s dispensing of five medicines at state-designated hospitals to combat influenza A and collected signatures from its members and ci...
Factive’s side effect cases top 34 for 6 years
The Korea Food and Drug Administration says that of 3,972 patients, a total of 34 cases of side-effects caused by Factive (gemifloxacin mesylate) have been reported for the recent six years (2003 to 2008).
It is ba...
Pharmaceutical stocks turning bullish on influenza A
Influenza A formerly known as swine flu, appears to have benefited some corporations in the medical and healthcare industries.
Shares of Myungmoon Pharm increased consecutively to its daily limits for October 27 an...
Dong-A, Daewoong enjoy brisk sales in domestic antiulcerant market
Dong-A Pharmaceutical and Daewoong Pharm saw their sales of Stillen and Albis soar in the third quarter of this year, according to market data.
Dong-A garnered 62.1 billion won in the accumulated nine-month of sale...
Dongwon calls for earlier commencement of direct transaction
Eight associate wholesalers of Dongwon Pharma Group have called on Pfizer Korea to promptly open its direct dealing with them so as to ensure more smooth distribution of drugs, in a recently issued statement.
The s...
Yoon stress revival of entrepreneurial spirit
Yoon Do-jun, incumbent chairman of Dongwha Pharmaceutical, said on October 26 reviving an entrepreneurial spirit is the key to to stay alive much longer.
In his key-note address in an international conference title...
LG Life Sciences develops innovative cytoprotective agent
LG Life Sciences Ltd. said on October 27 it will carry out the phase 1 clinical study of a drug for the treatment of stroke and myocardial infarction, in collaboration with Asan Medical Center.
The company said it ...
Daehwa gets Canada patent for oral paclitaxel
Daehwa Pharm said on October 26 that it has recently won Canada patent covering the oral form of widely used cancer drug paclitaxel, which is normally administered through injection, following its patent acquisition i...
Multinational firms urged to promote fair competition atmosphere
Domestic pharmaceutical wholesalers are vehemently criticizing the approaches of multinational drug manufacturers to allow their products to be sold by Zuellig Pharma Korea.
Their reaction came out after Pfizer Kor...
